HealthRX review

What it is

A cash-pay compounded GLP-1 service with a wider menu beside it: longevity (NAD⁺ injection and nasal spray, sermorelin, vitamin B12, glutathione and low-dose naltrexone), sexual health (sildenafil, tadalafil and PT-141), hair, skin and hormone care. It says it holds LegitScript certification under number 50087439 and links to the listing. Its structure is stated plainly: HealthRX is a platform that connects you with independent US-licensed clinicians and a licensed Section 503A compounding pharmacy. It says it does not employ the doctors, does not influence prescribing and does not own a pharmacy, and that it does not itself provide medical services or dispense medication. Service is offered to adults 18 and older in all 50 states.

How it works

The order runs payment first. You choose a plan and pay at checkout, then complete an online intake of about five minutes. An independent clinician licensed in your state reviews it, usually within about 24 hours, and may ask follow-up questions through the portal. If treatment is appropriate the prescription goes to the pharmacy and ships overnight with no signature needed; if you are not approved, you get a full refund and nothing ships or renews. HealthRX is explicit that payment does not guarantee a prescription. To qualify for a GLP-1 you need a BMI of 30 or higher, or 27 or higher with a weight-related condition such as prediabetes, high blood pressure, high cholesterol or sleep apnea. After you start, refills and provider messaging run through your account. To cancel, you email support and ask; the site says no phone call is needed and any unshipped dose is refunded. Support is a published email address and phone number rather than a form.

Pricing transparency

Every plan length is priced in the open. Compounded semaglutide is $149 for the first month on the monthly Subscribe & Save plan, then $165 a month; the prepaid plans are $399 for three months ($133 a month), $714 for six ($119) and $1,188 for twelve ($99). Compounded tirzepatide is $193 for the first month, then $214 a month; $627 for three months ($209), $1,194 for six ($199) and $2,148 for twelve ($179). The monthly plan is subscription only, and each monthly charge covers a four-week supply. Subscribe & Save renewals carry a standing $25 credit off the plan price, and HealthRX says renewals bill at or below the price you signed up at, with notice by email before any change. Every GLP-1 plan includes the provider review, the medication if prescribed, dose management, refill coordination and overnight shipping. One detail to check: the product page says injection supplies have not been confirmed as a standard inclusion, so ask which syringes come with your prescription. No insurance is required, and plans are HSA and FSA eligible.

Branded vs compounded

Compounded semaglutide and compounded tirzepatide, both once-weekly injections prepared by a licensed 503A pharmacy on a prescription written for you. HealthRX labels them as not FDA-approved and not the same product as the branded versions at the point of sale. The evidence handling is careful: the semaglutide page gives the STEP 1 average of 14.9% body-weight loss at 68 weeks on the 2.4 mg dose against 2.4% on placebo, and the side-by-side table cites the head-to-head trial of the branded drugs (13.7% for semaglutide, 20.2% for tirzepatide over 72 weeks), each with a note that those trials did not study compounded products. It also links the FDA's alert on dosing errors with compounded injectables and reminds you to use only the syringe instructions supplied with your prescription. The eligibility page lists who should not take a GLP-1: anyone with a personal or family history of medullary thyroid carcinoma or MEN-2, a history of severe pancreatitis, severe gastrointestinal disease, or who is pregnant or breastfeeding. The longevity and sexual-health products are priced separately (NAD⁺ injection from $161 a month, sermorelin from $179, PT-141 from $170, sildenafil from $62) and do not carry the outcome evidence the GLP-1s do.

Pros and watch-outs

The evidence behind what HealthRX prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term, but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Sermorelin benefits: does it work? What the trials show

  A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.

How HealthRX compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Enhance MD

  Lab-guided treatment under ongoing physician oversight

  See Enhance MD →
• OLOak Longevity

  Low-cost compounded GLP-1 bundled with a longevity stack

  See Oak Longevity →
• Direct Meds

  Straightforward compounded GLP-1 without an insurance requirement

  See Direct Meds →

More GLP-1 telehealth reviews: CaliberRx · Call-On-Doc · Candor Rx · Center for Medical Weight Loss (CMWL) · Better Med Spa · BeyondMD